| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 03 Apr | 382.35 |
-9.80 (-2.50%) |
OPEN
352.95 |
HIGH
412.00 |
LOW
333.35 |
| NSE 00:00 | 03 Apr | 382.40 |
-9.90 (-2.52%) |
OPEN
353.10 |
HIGH
411.95 |
LOW
333.50 |
| OPEN | 352.95 |
| PREVIOUS CLOSE | 392.15 |
| VOLUME | 678575 |
| 52-Week high | 838.00 |
| 52-Week low | 281.15 |
| P/E | 13.93 |
| Mkt Cap.(Rs cr) | 22,402 |
| Buy Price | 382.35 |
| Buy Qty | 25.00 |
| Sell Price | 382.00 |
| Sell Qty | 48.00 |
8.23 pm | 2 Apr 2020 | Business Standard
A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines
1.07 pm | 2 Apr 2020 | Business Standard
Novartis is donating 130 million hydroxychloroquine doses to support efforts against the epidemic, though the European Union has so far said there is ...
11.55 am | 27 Mar 2020 | Business Standard
The stock is trading higher for the fourth straight day and has rallied 38 per cent during the period.
8.51 am | 27 Mar 2020 | Business Standard
Here's a look at the top stocks that may remain in focus today -
11.43 am | 13 Mar 2020 | Business Standard
Aurobindo Pharma moved higher by 20 per cent to Rs 449, and witnessed 32 per cent rally in the intra-day deal.
10.04 am | 24 Feb 2020 | Business Standard
Currently, Unit 4 has 15 abbreviated new drug applications (ANDA) approvals pending over the next one year.
9.06 am | 24 Feb 2020 | Business Standard
Here's a look at the top stocks that may remain in focus today
10.58 am | 20 Feb 2020 | Business Standard
Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.
2.45 am | 20 Feb 2020 | Business Standard
Analysts remain positive on Aurobindo's future prospects including the US despite the higher base
4.54 pm | 19 Feb 2020 | Business Standard
The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from the US Food & Drug Administration...
9.34 am | 19 Feb 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
10.35 am | 7 Feb 2020 | Business Standard
The stock of the drug company was trading higher for the fifth straight day, up 14 per cent, against a 4 per cent rise in the S&P BSE Sensex during th...
8.59 am | 7 Feb 2020 | Business Standard
Here's a look at the top stocks that may trade actively in today's trading session
9.23 pm | 6 Feb 2020 | Press Trust of India
According to a filing with the bourses, revenues from operations during the quarter under review was up by nearly 12 per cent to Rs 5,895 crore. It wa...
4.07 pm | 6 Feb 2020 | Business Standard
All that happened in markets today.
4.37 pm | 30 Jan 2020 | Business Standard
The company in a filing on Thursday said the OAI classification will not have any material impact on the existing revenues or the supplies to its US b...
12.43 pm | 30 Jan 2020 | Business Standard
USFDA, that had conducted a Current Good Manufacturing Practice (cGMP) inspection at the company's Unit 7 an oral solids formulation manufacturing fac...
8.05 am | 30 Jan 2020 | Business Standard
The prime application of Moving Average is to find the direction of the trend, but it also identifies support and resistance levels
7.44 am | 22 Jan 2020 | Business Standard
Currently, Ramo Cements' stock is hovering in a range, after a sharp up move, offering fresh buying opportunity to those who missed the chance earlier
6.03 pm | 12 Dec 2019 | Press Trust of India
The product was distributed to major wholesalers/distributors who may have further distributed the product throughout the US, it added
